Real-world experience of commercial relmacabtagene autoleucel (relma-cel) for relapsed/refractory central nervous system lymphoma: a multicenter retrospective analysis of patients in China
Article in Journal for ImmunoTherapy of Cancer (May 2024)
The most recent citing publications are shown below. View all 35 publications that cite this research output on Dimensions.
Article in Journal for ImmunoTherapy of Cancer (May 2024)
Article in Frontiers in Pharmacology (January 2024)
Article in Therapeutic Advances in Hematology (January 2024)